Stock Research for PTX

Featured Broker: Ally Invest

Get the due diligence for another stock.


PTX Stock Chart & Research Data

The PTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PTX Due diligence Resources & Stock Charts

The PTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PTX Detailed Price Forecast - CNN Money CNN View PTX Detailed Summary - Google Finance
Yahoo View PTX Detailed Summary - Yahoo! Finance Zacks View PTX Stock Research & Analysis -

Stock Analysis

TradeIdeas View PTX Trends & Analysis - Trade-Ideas Barrons View PTX Major Holders - Barrons
NASDAQ View PTX Call Transcripts - NASDAQ Seeking View PTX Breaking News & Analysis - Seeking Alpha
Spotlight View PTX Annual Report - OTC Report View PTX OTC Short Report -
TradeKing View PTX Fundamentals - TradeKing Charts View PTX SEC Filings - Bar Chart
WSJ View Historical Prices for PTX - The WSJ Morningstar View Performance/Total Return for PTX - Morningstar
MarketWatch View the Analyst Estimates for PTX - MarketWatch CNBC View the Earnings History for PTX - CNBC
StockMarketWatch View the PTX Earnings - StockMarketWatch MacroAxis View PTX Buy or Sell Recommendations - MacroAxis
Bullish View the PTX Bullish Patterns - American Bulls Short Pains View PTX Short Pain Metrics -

Social Media Mentions

StockTwits View PTX Stock Mentions - StockTwits PennyStocks View PTX Stock Mentions - PennyStockTweets
Twitter View PTX Stock Mentions - Twitter Invest Hub View PTX Investment Forum News - Investor Hub
Yahoo View PTX Stock Mentions - Yahoo! Message Board Seeking Alpha View PTX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PTX - Insider Cow View Insider Transactions for PTX - Insider Cow
CNBC View PTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PTX - OTC Markets
Yahoo View Insider Transactions for PTX - Yahoo! Finance NASDAQ View Institutional Holdings for PTX - NASDAQ

Stock Charts

FinViz View PTX Stock Insight & Charts - StockCharts View PTX Investment Charts -
BarChart View PTX Stock Overview & Charts - BarChart Trading View View PTX User Generated Charts - Trading View

Latest Financial News for PTX

[$$] Drug Maker Pernix Therapeutics Files for Bankruptcy, Blaming Competition From Generics
Posted on Tuesday February 19, 2019

Holdings Inc., which makes painkiller Zohydro and other medications, has filed for bankruptcy protection after drug sales to consumers fell below expectations. It blamed a revenue drop partly on fresh competition with generic versions of its migraine treatment Treximet. In documents filed in U.S. Bankruptcy Court in Wilmington, Del., company officials said they already have a $76 million offer from affiliates of Highbridge Capital Management LLC, which offered to pay cash and forgive some of its debt.

Pernix Therapeutics Holdings, Inc. Enters into Asset Purchase Agreement with Certain Funds Managed by Highbridge Capital Management
Posted on Tuesday February 19, 2019

Pernix Therapeutics Holdings, Inc. (PTX) (“Pernix” or the “Company”), a holding company that owns several subsidiaries, including specialty pharmaceutical companies, today announced that it has entered into an Asset Purchase Agreement with certain funds managed by Highbridge Capital Management, LLC (collectively “Highbridge”). The Agreement serves as an initial “stalking-horse bid” to acquire substantially all of the assets of the Company and its subsidiaries, including the rights to all branded and generic products (the “Products”), for approximately $75.6 million in the form of cash and credit bid consideration. Pernix has also initiated voluntary proceedings under Chapter 11 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware to undertake its restructuring and sale process.

Could The Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) Ownership Structure Tell Us Something Useful?
Posted on Saturday February 16, 2019

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Every investor in Pernix Therapeutics Holdings, Inc.Read More...

Analyst Reports Pernix Therapeutics Holdings, Inc. is Laying the Foundation for a Turnaround
Posted on Thursday February 14, 2019

NEW YORK, NY / ACCESSWIRE / February 14, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Pernix Therapeutics Holdings, Inc., (PTX) Pernix is the parent company of Pernix Therapeutics, LLC, a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs, primarily for the U.S. market. During the third quarter, Contrave remained the leading prescription weight loss brand in the United States, and the company is currently exploring a number of initiatives to enhance the value of the brand globally. Pernix is extremely encouraged with the initial results from Contrave, which is the market-leading branded weight loss prescription drug.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.